Elacestrant vs fulvestrant or aromatase inhibitor (AI) in phase III trial evaluating elacestrant, an oral selective estrogen receptor degrader (SERD), vs standard of care (SOC) endocrine monotherapy for ER+/HER2-advanced/metastatic breast cancer (mBC): Subgroup analysis from EMERALD

被引：6

作者：

Aftimos, P. G. ^{[1
]}

Cortes, J. ^{[2
]}

Bidard, F. C. ^{[3
]}

Kaklamani, V. ^{[4
]}

Bardia, A. ^{[5
]}

Neven, P. ^{[6
]}

Streich, G. ^{[7
,8
]}

Montero, A.

Forget, F. ^{[9
]}

Reynier, M. A. Mouret ^{[10
]}

Sohn, J. ^{[11
]}

Taylor, D. ^{[12
]}

Harnden, K. ^{[13
]}

Khong, H. ^{[14
]}

Kocsis, J. ^{[15
]}

Dalenc, F. ^{[16
]}

Dillon, P. ^{[17
]}

Tonini, G. ^{[18
]}

Grzegorzewski, K. J. ^{[19
]}

Lu, J. ^{[20
]}

机构：

[1] Inst Jules Bordet, Clin Trials Conduct Unit, Brussels, Belgium

[2] Int Breast Canc Ctr IBCC, Quiron Grp, Med Oncol, Barcelona, Spain

[3] Inst Curie, Med Oncol Dept, Paris, France

[4] UTHSCSA Univ Texas Hlth Sci Ctr San Antonio, 303 Regent Circle, San Antonio, TX USA

[5] Harvard Med Sch, Massachusetts Gen Hosp, Canc Ctr, Haematol Oncol, Boston, MA USA

[6] Univ Hosp Leuven, Multidisciplinary Breast Ctr, Dept Gynaecol Oncol, Campus Gasthuisberg, Leuven, Belgium

[7] Hosp Mil Cent Cirujano Mayor Dr Cosme Argerich, Buenos Aires, Argentina

[8] Case Western Reserve Univ, Med Oncol, Cleveland, OH USA

[9] Ctr Hosp Ardenne, Med Oncol, Libramont, Belgium

[10] Jean Perrin Ctr, Med Oncol, Clermont Ferrand, France

[11] Yonsei Univ, Med Oncol Dept, Seoul, South Korea

[12] CHU UCL Namur Site St Elisabeth, Dept Oncol, Namur, Belgium

[13] Inova Schar Canc Inst, Med Oncol, Fairfax, VA USA

[14] H Lee Moffitt Canc Ctr & Res Inst, Med Oncol, Magnolia Campus, Tampa, FL USA

[15] Bacs Kiskun Cty Teaching Hosp Kecskemet, Oncol Dept, Kecskemet, Hungary

[16] Ctr Claudius Regaud, Clin Res, Toulouse, France

[17] UVA Univ Virginia, Med Oncol, Sch Med, Div Hematol & Oncol, Charlottesville, VA USA

[18] Menarini Silicon Biosyst Inc, North Amer Operat, Med Oncol, Huntingdon Valley, PA USA

[19] Stemline Therapeut Inc, Clin Dev, New York, NY USA

[20] USC Univ Southern Calif, Med Dept, Norris Comprehens Canc Ctr, Los Angeles, CA USA

来源：

ANNALS OF ONCOLOGY | 2022年 / 33卷 / 07期

关键词：

D O I：

10.1016/j.annonc.2022.07.259

中图分类号：

R73 [肿瘤学];

学科分类号：

100214 ;

摘要：

220P

引用

页码：S638 / S638

页数：1